What is Merck & Co., Inc. (MRK)?

Merck & Co., Inc. (MRK) is a stock in the Healthcare sector, Drug Manufacturers - General industry. View full analysis on Stocks360.

What is the current price of MRK?

The current price of MRK is $141.12. Prices are updated in real time on Stocks360.

What is MRK's price-to-earnings (PE) ratio?

MRK's trailing twelve-month PE ratio is 112.00, based on current price and earnings per share data available on Stocks360.

What is MRK's market capitalization?

MRK's market capitalization is $348,167,261,555.00, placing it in the large-cap tier.

Does MRK pay a dividend?

Yes. MRK has a trailing twelve-month dividend yield of 0.02%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Merck & Co., Inc. (MRK)

Stock analysis · NYSE · Healthcare · Drug Manufacturers - General

$141.12

Market Cap

$348.17B

PE (TTM)

112.00

EPS (TTM)

N/A

Dividend Yield

2.41%

Beta

0.22

Day Range

$139.21 – $142.40

52-wk Range

$82.01 – $156.92

Avg Volume

N/A

Volume

8.19M

Merck & Co., Inc. (MRK) is a publicly traded company in the Healthcare sector. Latest price: $141.12. Market cap $348.17B. Trailing PE 112.00. Dividend yield 2.41%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $86.58 2026-10-28 · $140.93 (+62.77%)

Earnings

Most Recent

Aug 4, 2026

EPS $-0.13 vs est. $-0.27

Beat by $0.14

Proprietary Signals

Signal snapshot temporarily unavailable.

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distribu…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	112.00×
P/S (TTM)	5.24×
P/B	8.32×
P/FCF (TTM)	21.68×
EV / EBITDA	28.38×
EV / Sales	5.95×
Earnings Yield	0.91%
Free Cash Flow Yield	4.61%
Dividend Yield	2.41%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$395.22B
Revenue (TTM)	$66.40B
Net Income (TTM)	$3.17B
Free Cash Flow (TTM)	$16.74B
Net Debt	$47.06B
Working Capital	$8.95B
Gross Margin	75.38%
Operating Margin	16.65%
Net Margin	4.78%
Return on Equity	6.60%
Return on Invested Capital	5.62%